Categories AlphaGraphs, Analysis, Energy

Earnings Preview: Will the Trump effect translate to Plug Power in Q3?

Hydrogen fuel cell maker Plug Power Inc (PLUG) is expected to post its third-quarter earnings result before the opening bell on Thursday, November 8. Trump’s latest administrative effects are expected to help the company as the US manufacturing sector has picked up on increased capital spending and hiring driven by massive tax overhaul, deregulatory measures, strong domestic economy and robust business sentiment.

Nevertheless, the Street estimates sales of $48.56 million in the quarter for the alternative power company, which is 21% lower than last year’s $61.43 million.

Plug Power Q3 2018 Earnings Preview
Plug Power’s GenSure E-2200x fuel cell (Courtesy: Plug Power)

Last quarter, Plug Power Inc. (PLUG) posted a loss of $0.12 per share on revenues of $39.9 million, missing estimates — even after it posted an impressive top-line growth vs. a year ago.

This was the same period when the company started shipping its new GenDrive 2440-36R fuel cell system used in Class-2 electric forklifts.

Almost $20 million in total operating expenses affected the bottom-line, and this will also be in focus in the coming results.

However, since the US manufacturing sector has witnessed a resurgence under the Trump administration from how it was last year, we could see this translate to Power Plug. Be on the lookout for expense cuts and tax gains when the results are out on Thursday.

 

Listen to publicly listed companies’ earnings conference calls along with the edited closed caption text.

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top